BYRON BLEDSOE: Open Payments
NPI 1174269310 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 16 payments from 9 companies in 2025. Trend: 2023 $350 · 2024 $216 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $149 |
| Teva Pharmaceuticals USA, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| ABBVIE INC. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Alkermes, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
Products named: Korlym, AUSTEDO XR, REXULTI, VRAYLAR, INVEGA SUSTENNA, ARISTADA, CAPLYTA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
